2023
DOI: 10.3389/fonc.2022.1018617
|View full text |Cite
|
Sign up to set email alerts
|

Undifferentiated hepatic carcinoma with osteoclast-like giant cells: A case report and literature review

Abstract: Osteoclast-like giant cell tumor (OGCT) is a common bone tumor, occasionally observed in some extraosseous organs, but rarely involving the digestive system, especially the liver. Previously reported osteoclast-like giant cell carcinoma of the liver often coexists with sarcomatoid or hepatocellular carcinoma. Undifferentiated liver tumors with osteoclast-like giant cells (OGCs) are extremely rare. Due to its rarity, there is no consensus for diagnosis and treatment of undifferentiated liver tumors with OGCs. D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 35 publications
0
3
0
Order By: Relevance
“…Hepatocellular carcinoma (HCC) with osteoclastlike giant cells (OGCs) is extremely rare and was first described and reported by Munoz [19]. To date, including our case, there have been only 20 reported cases [19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37]. Westra et al [24] reported a liver consultation case without detailed patient information.…”
Section: Discussionmentioning
confidence: 82%
See 2 more Smart Citations
“…Hepatocellular carcinoma (HCC) with osteoclastlike giant cells (OGCs) is extremely rare and was first described and reported by Munoz [19]. To date, including our case, there have been only 20 reported cases [19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37]. Westra et al [24] reported a liver consultation case without detailed patient information.…”
Section: Discussionmentioning
confidence: 82%
“…Clinical and pathological information, such as gender, age, tumor size, clinical presentation, neoadjuvant therapy, underlying liver disease, location of surgery, histopathological diagnosis, cirrhosis, CD68 expression in OGCs, and clinical outcomes were collected for each patient. Detailed clinical and pathological information for these cases, including our case, is presented in Additional file 1: Table S1 [ [19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37].…”
Section: Literature Reviewmentioning
confidence: 99%
See 1 more Smart Citation